Company intelligence / Profile preview
Zelira Therapeutics
Perth, Western Australia, Australiazeliratx.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Zelira Therapeutics develops proprietary cannabinoid-based medicines targeting unmet needs in conditions like autism spectrum disorder, insomnia, chronic pain, and rare neurodevelopmental syndromes. Its lead program HOPE® has shown improvements in clinical global impression scores for ASD patients. Zenivol®, its insomnia product, demonstrated statistically significant improvement on the Insomnia Severity Index in a Phase Ib/IIa trial. The company uses real-world patient data to inform rapid commercialization strategies alongside formal FDA pathways.
- Therapeutic areas
- PsychiatryRare DiseasesNeurology
- Modalities
- Small moleculeControlled substanceEncapsulation technology
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Distribution partnerships with Health House International Ltd.research collaborations with Curtin UniversityTelethon Kids InstituteUniversity of Western AustraliaSt Vincent’s Hospital Melbourne & Children’s Hospital of Philadelphia.
Beyond the preview
Go deeper on Zelira Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zelira Therapeutics.